MedPath

AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

121

FDA:114
NMPA:7

Drug Approvals

Temozolomide Capsules

Product Name
替莫唑胺胶囊
Approval Number
国药准字HJ20250064
Approval Date
May 27, 2025
NMPA

Temozolomide Capsules

Product Name
替莫唑胺胶囊
Approval Number
国药准字HJ20250065
Approval Date
May 27, 2025
NMPA

Abiraterone Acetate Tablets

Product Name
醋酸阿比特龙片
Approval Number
国药准字HJ20240134
Approval Date
Nov 15, 2024
NMPA

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字HJ20240058
Approval Date
Jul 30, 2024
NMPA

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字HJ20240059
Approval Date
Jul 30, 2024
NMPA

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字HJ20240057
Approval Date
Jul 30, 2024
NMPA

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字HJ20230112
Approval Date
Oct 12, 2023
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath